What causes fatigue and obesity?

Fatigue and obesity often co-occur and can form a self-perpetuating cycle rooted in complex physiological, behavioral, and endocrine mechanisms. Obesity contributes to fatigue through multiple pathways: excess adipose tissue promotes chronic low-grade systemic inflammation, elevating pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which are associated with central nervous system fatigue and reduced motivation. Adipose tissue also dysregulates leptin and adiponectin secretion—leading to leptin resistance—which impairs satiety signaling and disrupts hypothalamic regulation of energy balance and arousal. Additionally, obesity is strongly linked to obstructive sleep apnea (OSA), resulting in fragmented, non-restorative sleep and daytime somnolence. Metabolic consequences—including insulin resistance, dyslipidemia, and mitochondrial dysfunction in skeletal muscle—further diminish cellular energy production and physical endurance.

Conversely, persistent fatigue can drive weight gain by reducing spontaneous physical activity (non-exercise activity thermogenesis, or NEAT), impairing executive function and decision-making related to dietary choices, and increasing reliance on high-calorie, ultra-processed foods for quick energy. Hormonal shifts associated with chronic fatigue—such as elevated cortisol and blunted growth hormone secretion—promote visceral fat accumulation and muscle catabolism. Underlying medical conditions commonly contributing to both symptoms include hypothyroidism, major depressive disorder, chronic fatigue syndrome (myalgic encephalomyelitis), type 2 diabetes, and cardiovascular disease. A thorough clinical evaluation—including thyroid function tests, fasting glucose and HbA1c, lipid panel, inflammatory markers (e.g., CRP), and sleep assessment—is essential to identify treatable contributors and guide personalized, multidisciplinary management.